EW
Edwards Lifesciences Corp
NYSE · Healthcare · Medical - Devices · US
$99.40
+4.42%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$98.58
From 52W high+0.00%
Volume5.07M
Market cap$57.29B
P/E (TTM)57.1x
P/S (TTM)8.8x
Div yield—
Key dataNov 4, 2026
Open
$98.58
From 52W high
+0.00%
Volume
5.07M
Market cap
$57.29B
ValuationView details →
P/E (Fwd)
30.6x
EV/EBITDA
34.0x
P/E (TTM)
57.1x
RSI (14)
72.9
MomentumView details →
1D Return
+4.42%
YTD Return
+16.13%
SummaryUpdated Jun 1, 2026
Edwards Lifesciences Corporation (NYSE:EW) is a leading medical device company founded in 1958 and headquartered in Irvine, California. The company has evolved from its origins as a division of American Hospital Supply Corporation to become a specialized leader in structural heart disease and critical care monitoring technologies. Edwards went public in 2000 and has since focused increasingly on structural heart therapies, completing the sale of its Critical Care business in 2024 to concentrate solely on treating heart valve diseases and related conditions.
Similar companies
Latest newsMore news →
Edwards Lifesciences announced that its PASCAL system demonstrated superiority to medical therapy alone on the Edwards Lifesciences Corp’s six-month primary endpoint, with reduced tricuspid regurgitation and improved health status sustained through one year.2d agoEdwards Lifesciences Corp announced that the Edwards Lifesciences Corp found TAVR superior to clinical surveillance for the primary composite endpoint of death or heart failure events at two years among moderate aortic stenosis patients with at-risk features.2d ago